Abstract
Pericarditis is the most common form of pericardial disease and may be associated with significant morbidity and mortality. Management of idiopathic pericarditis includes pharmacologic therapies, non-pharmacologic therapies, and surgery. This article describes the diagnosis and management of idiopathic causes of pericarditis, incorporating recommendations included in the European Society of Cardiology guidelines.
MeSH terms
-
Acute Disease
-
Adrenal Cortex Hormones / therapeutic use*
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Aspirin / therapeutic use
-
Azathioprine / therapeutic use
-
Colchicine / therapeutic use*
-
Disease Management
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use
-
Immunologic Factors / therapeutic use
-
Immunosuppressive Agents / therapeutic use*
-
Interleukin 1 Receptor Antagonist Protein / therapeutic use
-
Pericardial Window Techniques*
-
Pericarditis / diagnostic imaging
-
Pericarditis / therapy*
-
Practice Guidelines as Topic
-
Recurrence
-
Tubulin Modulators / therapeutic use*
Substances
-
Adrenal Cortex Hormones
-
Anti-Inflammatory Agents, Non-Steroidal
-
Immunoglobulins, Intravenous
-
Immunologic Factors
-
Immunosuppressive Agents
-
Interleukin 1 Receptor Antagonist Protein
-
Tubulin Modulators
-
Azathioprine
-
Aspirin
-
Colchicine